Back to search

University of Thessaly (UTH)

Επίδραση της φαρμακευτικής αγωγής στη μεσοτοιχωματική κλασματική βράχυνση σε ασθενείς με αρτηριακή υπέρταση

Abstract

dc:description

The present study was designed to assess the effect of two novel drugs, nebivolol, a highly selective beta 1 adrenoreceptor blocking agent with peripheral vasodilating properties, and telmisartan, a highly selective antagonist of type 1 angiotensin II receptors on arterial blood pressure (BP) and left ventricular (LV) structure and performance in untreated patients with essential hypertension. 40 patients with mild to moderate hypertension were randomized to receive either nebivolol (2,5 – 5,0 mg/d) or telmisartan (40 – 80 mg/d) to achieve a target diastolic BP of < 90 mmHg, and 19 healthy volunteers served as controls. BP was measured with sphygmomanometry, whereas LV mass and midwall fractional shortening (mFS) were estimated by 2D-guided M-mode echocardiography and LV diastolic filling was evaluated by Doppler echocardiography at baseline and at the three-month follow-up. Age, sex distribution, and baseline heart rate, body mass index and systolic and diastolic BP were similar in the two drug groups. Both nebivolol and telmisartan reduced systolic (156 ± 7 vs 124 ± 8 mmHg, p<0,01 and 153 ± 5 vs 120 ± 7 mmHg, p< 0,01, respectively) and diastolic BP (99 ± 4 vs 80 ± 2 mmHg, p<0,01 and 98 ± 2 vs 80 ±2 mmHg, p<0,01, respectively) and increased mFS (16 ± 2% vs 19 ± 2%, p<0,01 and 15 ± 2% vs 18 ± 2%, p<0,01, respectively). LV mass index decreased significantly with both nebivolol (98 ± 16 vs 84 ± 13 g/m2, p<0,01) and telmisartan (97 ± 13 vs 83 ± 8 g/m2, p<0,01). mFS was inversely related to diastolic blood pressure in the nebivolol but not in the telmisartan group. The findings of the present study indicate that abnormalities of midwall mechanics parallel those of transmitral diastolic flow in untreated patients with mild to moderate essential hypertension and normal LV ejection fraction. The disparity between midwall and endocardial mechanics confirms the need to measure mFS to track the beneficial effect of antihypertensive treatment. Nebivolol and telmisartan are equally effective in decreasing systolic and diastolic blood pressure and in increasing mFS. There may be differences between nebivolol and telmisartan regarding the mechanism of increase in mFS.

Degree

thesis:*
Grantor dc:publisher
University of Thessaly (UTH)
Year dc:date
2005

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Fountoulaki, Ekaterini
  • Φουντουλάκη, Αικατερίνη

Subjects

dc:subject × 12

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/33972

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Fountoulaki, Ekaterini; Φουντουλάκη, Αικατερίνη. Επίδραση της φαρμακευτικής αγωγής στη μεσοτοιχωματική κλασματική βράχυνση σε ασθενείς με αρτηριακή υπέρταση. University of Thessaly (UTH), 2005. http://hdl.handle.net/10442/hedi/33972